| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 01/02/2003 | US20030004173 Pharmaceutically active compounds |
| 01/02/2003 | US20030004166 Novel triazine compounds useful as sorbitol dehydrogenase inhibitors |
| 01/02/2003 | US20030004164 Anticancer agents; autoimmune diseases |
| 01/02/2003 | US20030004162 Antidiabetic agents; dietetics |
| 01/02/2003 | US20030004161 Anticancer agents; autoimmune diseases |
| 01/02/2003 | US20030004158 Kinase inhbitor; antiproliferative agents |
| 01/02/2003 | US20030004137 Muscle relaxants, controlling immunology, strokes, antidiabetic agents |
| 01/02/2003 | US20030003396 Reflection, protective or covering layers which can be written on or read by blue, red or infrared light |
| 01/02/2003 | US20030003049 Simultaneous dual isotope imaging of cardiac perfusion and cardiac inflammation |
| 01/02/2003 | EP1270567A1 Pyrazoline derivatives or tetrahydropyridazine derivatives and medicinal use thereof |
| 01/02/2003 | EP1270560A1 Hiv replication inhibiting pyrimidines |
| 01/02/2003 | EP1270557A1 Ethylenediamine derivatives |
| 01/02/2003 | EP1270555A1 Method for oxidizing a thioether group into a sulfoxide group |
| 01/02/2003 | EP1268479A1 Phenyl-substituted indolizine derivatives and their use as histamine h3 ligands |
| 01/02/2003 | EP1268478A2 Phenyl-substituted imidazopyridines |
| 01/02/2003 | EP1268469A1 N-(heterocyclyl)benzene or pyridine sulphonamides as antithrombotic agents and anticoagulants |
| 01/02/2003 | EP1268468A1 4-amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazoline mesylat and polymorphs |
| 01/02/2003 | EP1268467A1 Heteroaromatic compounds having two-photon absorption activity |
| 01/02/2003 | EP1268466A1 Decahydro-isoquinolines |
| 01/02/2003 | EP1268465A1 Triarylimidazole derivatives as cytokine inhibitors |
| 01/02/2003 | EP1268455A2 Piperazine derivatives |
| 01/02/2003 | EP1268454A1 Succinoylamino heterocycles as inhibitors of a-beta protein production |
| 01/02/2003 | EP1268449A1 Substituted piperidines as melanocortin receptor agonists |
| 01/02/2003 | EP1268445A1 4-amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases |
| 01/02/2003 | EP1268444A1 2,4-di(hetero-)arylamino(-oxy)-5-substituted pyrmidines as antineoplastic agents |
| 01/02/2003 | EP1268437A1 Inhibitors of protein kinases |
| 01/02/2003 | EP1268435A1 4,5-dihydro-1h-pyrazole derivatives having cb 1-antagonistic activity |
| 01/02/2003 | EP1268433A1 Cyclic lactams as inhibitors of a-beta-protein production |
| 01/02/2003 | EP1268432A1 ISOQUINOLONE INHIBITORS OF FACTOR Xa |
| 01/02/2003 | EP1268431A1 3-cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors |
| 01/02/2003 | EP1268429A1 Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same |
| 01/02/2003 | EP1268428A2 Polycyclic aryl and heteroaryl substituted 4-pyridones useful for selective inhibition of the coagulation cascade |
| 01/02/2003 | EP1268422A1 Indoles for treating diseases that can be treated using thyroid hormones |
| 01/02/2003 | EP1268421A2 Phenyl-substituted indoles as histamine h3-receptor antagonists |
| 01/02/2003 | EP1268419A1 Pyrrolidine derivatives useful as bax inhibitors |
| 01/02/2003 | EP1268418A1 Pharmaceutically active pyrrolidine derivatives as bax inhibitors |
| 01/02/2003 | EP1267878A2 Compounds with 5-ht activity useful for controlling visual field loss |
| 01/02/2003 | EP1267876A1 Thrombin inhibitors |
| 01/02/2003 | EP1267874A2 Therapeutic uses of ppar mediators |
| 01/02/2003 | EP1267872A2 Farnesyl protein transferase inhibitor combinations with anti-tumor anthracycline derivatives |
| 01/02/2003 | EP1267870A2 Inhibition of cytokine generation |
| 01/02/2003 | EP1267848A1 Dosing regimen comprising a farnesyl protein transferase inhibitor for the treatment of cancer |
| 01/02/2003 | EP1109785B1 Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation |
| 01/02/2003 | EP1083897A4 Hiv integrase inhibitors |
| 01/02/2003 | EP0934265B1 Amidinophenyl-pyrrolidines, -pyrrolines, and -isoxazolidines and derivatives thereof |
| 01/02/2003 | EP0925286B1 Substituted pyrimidine derivatives and their pharmaceutical use |
| 01/02/2003 | EP0804431B9 GLYCOPROTEIN IIb/IIIa ANTAGONISTS |
| 01/02/2003 | EP0751939B9 Naphthylamides as central nervous system agents |
| 01/02/2003 | EP0705245B1 Novel intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives |
| 01/02/2003 | CA2414726A1 Bicyclic lactams and sulfonamides with 5-ht1a-affinity and use thereof for preventing and treating cerebral ischaemia |
| 01/01/2003 | CN1097592C Slfonic acid amide derivatives with herbicides activity |
| 01/01/2003 | CN1097591C Process for preparing pyrimidine derivatives |
| 12/31/2002 | US6500959 Pyrrolidine derivatives and processes for preparing same |
| 12/31/2002 | US6500956 Method for the catalytic production of substituted bipyridyl derivatives |
| 12/31/2002 | US6500955 One pot synthesis of [2,8-Bis (trifluoromethyl)-4-quinolinyl]-2-pyridinylmethanone, a mefloquine intermediate |
| 12/31/2002 | US6500950 Benzylidenepyrazolones, their preparation and use |
| 12/31/2002 | US6500948 Metalloproteinase inhibitors-compositions, uses preparation and intermediates thereof |
| 12/31/2002 | US6500855 Nitrogen containing aromatic heterocycles with ortho-substituted p1 groups; anticoagulants |
| 12/31/2002 | US6500854 Chondrongenesis promotors and indolin-2-one derivatives |
| 12/31/2002 | US6500852 Inhibitors of bacterial NAD synthetase |
| 12/31/2002 | US6500851 Antithrombotic agents |
| 12/31/2002 | US6500850 Pesticidal 1-arylpyrazoles |
| 12/31/2002 | US6500846 2-(4-chlorophenyl)-7-methoxychromen-4-one, as cyclin-dependent kinase inhibitors, used as anticarcinogenic agents or for prophylaxis of neurodegenerative disease |
| 12/31/2002 | US6500845 Activating cytokine release using immunosuppressants such as 2-(3-methyl-2-oxo-piperidin-3-yl)-benzo(d)isoselenazol-3-one, racemic mixtures or isomers having dimensional stability, prepared in the presence of reducing agent |
| 12/31/2002 | US6500844 Cyclopentyl modulators of chemokine receptor activity |
| 12/31/2002 | US6500842 N-((4-chlorophenyl)methyl)-8-hydroxy-7-quinolinecarboxamide administered as viricides against herpes virus |
| 12/31/2002 | US6500823 Energy deficiency of the cell caused by parp inhibition, in diabetes complications, in oxygen deficient status of the heart and brain, in neurodegenerative diseases, in the treatment of autoimmune and/or viral diseases |
| 12/31/2002 | US6500822 Benzocycloalkylenylamine derivatives as muscarinic receptor antagonists |
| 12/31/2002 | US6500821 Treat various forms of epilepsies and of states of anxiety and tension. |
| 12/31/2002 | US6500818 Naphthalenecarboxamides as tachykinin receptor antagonists |
| 12/27/2002 | WO2002102793A2 Quinazolinediones as antibacterial agents |
| 12/27/2002 | WO2002102792A1 Novel heterocyclic antibacterial compounds |
| 12/27/2002 | WO2002102791A1 Pyrrolidine bicyclic compounds |
| 12/27/2002 | WO2002102790A1 N-formyl hydroxylamine compounds as inhibitors of pdf |
| 12/27/2002 | WO2002102787A2 Novel sulfonic acid derivatives |
| 12/27/2002 | WO2002102782A2 QUINAZOLINE DERIVATIVES which PROMOTE THE RELEASE OF PARATHYROID_HORMONE |
| 12/27/2002 | WO2002102778A1 Phenylpyridine carbonyl piperazine derivative |
| 12/27/2002 | WO2002102380A1 Monocyclic or bicyclic carbocycles and heterocycles as factor xa inhibitors |
| 12/27/2002 | WO2002102359A2 Alkylidene pyrazolidinedione derivatives and use for treating diabetes and obesity |
| 12/27/2002 | WO2002102315A2 QUINAZOLINE AND PYRIDO[2,3-d]PYRIMIDINE INHIBITORS OF PHOSPHODIESTERASE (PDE) 7 |
| 12/27/2002 | WO2002102314A2 Purine inhibitors of phosphodiesterase (pde) 7 |
| 12/27/2002 | WO2002092565A3 3-aminoalkyl-2-aryl-indole derivatives and their use as gnrh antagonists |
| 12/27/2002 | WO2002074753A3 5-phenylpyrimidine, methods and intermediate products for the production thereof and use of the same for controlling pathogenic fungi |
| 12/27/2002 | WO2002056888A3 Assay method, tnf modulator and its use |
| 12/27/2002 | WO2002055609A3 Indole/indoline based hybrid dyes and indole/indoline based hybrid dye intermediate products |
| 12/27/2002 | WO2002046181A3 Abca-1 elevating compounds against coronary artery disease or atherosclerosis |
| 12/27/2002 | WO2002009758A3 Inhibitors of cellular efflux pumps of microbes |
| 12/27/2002 | WO2001085095B1 Chiral fluoroquinolizinone arginine salt forms |
| 12/27/2002 | WO2001052855A8 Drug combination for the treatment of depression and related disorders comprising mirtazapine and gepirone |
| 12/27/2002 | CA2450936A1 Purine inhibitors of phosphodiesterase (pde) 7 |
| 12/27/2002 | CA2450724A1 Quinazoline and pyrido¬2,3-d|pyrimidine inhibitors of phosphodiesterase (pde) 7 |
| 12/27/2002 | CA2449212A1 Alkylidene pyrazolidinedione derivatives and use for treating diabetes and obesity |
| 12/27/2002 | CA2448526A1 N-formyl hydroxylamine compounds as inhibitors of pdf |
| 12/27/2002 | CA2448298A1 Phenylpyridine carbonyl piperazine derivative |
| 12/27/2002 | CA2446963A1 Quinazolinediones as antibacterial agents |
| 12/27/2002 | CA2446931A1 Pyrrolidine bicyclic compounds |
| 12/27/2002 | CA2429113A1 Monocyclic or bicyclic carbocycles and heterocycles as factor xa inhibitors |
| 12/26/2002 | US20020198407 Antiallergy agents and bronchodilators |
| 12/26/2002 | US20020198383 For use in regioselective and enantioselective alkylations of allylic substrates |
| 12/26/2002 | US20020198381 Herbicidal pyridine compounds |